Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apolipoprotein C-III | 44 | 2023 | 210 | 8.920 |
Why?
|
Lipoproteins, HDL | 39 | 2024 | 675 | 6.630 |
Why?
|
Diet, Reducing | 60 | 2024 | 485 | 5.320 |
Why?
|
Lipoproteins, VLDL | 31 | 2023 | 201 | 4.400 |
Why?
|
Coronary Disease | 63 | 2022 | 5921 | 4.270 |
Why?
|
Apolipoproteins B | 29 | 2023 | 385 | 4.160 |
Why?
|
Cholesterol, HDL | 47 | 2023 | 1812 | 4.080 |
Why?
|
Weight Loss | 65 | 2024 | 2680 | 3.980 |
Why?
|
Lipoproteins, LDL | 32 | 2023 | 643 | 3.730 |
Why?
|
Apolipoproteins E | 22 | 2023 | 1443 | 3.510 |
Why?
|
Hypertriglyceridemia | 16 | 2016 | 292 | 3.480 |
Why?
|
Dietary Fats | 62 | 2022 | 1994 | 3.440 |
Why?
|
Pravastatin | 47 | 2014 | 392 | 3.410 |
Why?
|
Dietary Carbohydrates | 31 | 2024 | 891 | 3.210 |
Why?
|
Triglycerides | 54 | 2023 | 2457 | 3.100 |
Why?
|
Dietary Fats, Unsaturated | 15 | 2019 | 224 | 3.010 |
Why?
|
Anticholesteremic Agents | 37 | 2021 | 968 | 2.950 |
Why?
|
Apolipoprotein A-I | 18 | 2024 | 299 | 2.920 |
Why?
|
Lipoproteins | 32 | 2023 | 877 | 2.840 |
Why?
|
Overweight | 50 | 2024 | 2418 | 2.660 |
Why?
|
Dietary Proteins | 31 | 2024 | 951 | 2.450 |
Why?
|
Diet, Fat-Restricted | 25 | 2024 | 329 | 2.410 |
Why?
|
Apolipoproteins C | 11 | 2006 | 59 | 2.350 |
Why?
|
Diet, Carbohydrate-Restricted | 7 | 2024 | 263 | 2.290 |
Why?
|
Cholesterol | 56 | 2023 | 2902 | 2.250 |
Why?
|
Obesity | 72 | 2024 | 12940 | 2.250 |
Why?
|
Cholesterol, LDL | 46 | 2015 | 2380 | 2.120 |
Why?
|
Apolipoproteins | 14 | 2023 | 327 | 1.970 |
Why?
|
Cardiovascular Diseases | 72 | 2024 | 15521 | 1.930 |
Why?
|
Insulin Resistance | 27 | 2024 | 3952 | 1.700 |
Why?
|
Hypolipidemic Agents | 13 | 2019 | 609 | 1.610 |
Why?
|
Diet, Mediterranean | 8 | 2024 | 738 | 1.570 |
Why?
|
Diet, Sodium-Restricted | 14 | 2023 | 291 | 1.550 |
Why?
|
Atherosclerosis | 19 | 2024 | 3407 | 1.280 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 34 | 2024 | 3245 | 1.270 |
Why?
|
Diet | 47 | 2023 | 8048 | 1.240 |
Why?
|
Glycemic Index | 7 | 2023 | 396 | 1.200 |
Why?
|
Hyperlipidemias | 11 | 2021 | 771 | 1.200 |
Why?
|
Blood Pressure | 56 | 2023 | 8479 | 1.150 |
Why?
|
Cholesterol Ester Transfer Proteins | 8 | 2021 | 113 | 1.130 |
Why?
|
Hypertension | 53 | 2023 | 8536 | 1.120 |
Why?
|
American Heart Association | 16 | 2021 | 1043 | 1.070 |
Why?
|
Diabetes Mellitus, Type 2 | 27 | 2023 | 12159 | 1.040 |
Why?
|
Lipid Metabolism | 10 | 2024 | 1893 | 1.010 |
Why?
|
Caloric Restriction | 10 | 2023 | 299 | 0.960 |
Why?
|
Apolipoproteins A | 4 | 2023 | 95 | 0.960 |
Why?
|
Fenofibrate | 3 | 2010 | 87 | 0.960 |
Why?
|
Apolipoprotein B-100 | 7 | 2023 | 157 | 0.940 |
Why?
|
Dyslipidemias | 9 | 2018 | 870 | 0.920 |
Why?
|
Adiposity | 19 | 2023 | 1879 | 0.900 |
Why?
|
Middle Aged | 248 | 2024 | 220858 | 0.900 |
Why?
|
Lipoproteins, IDL | 7 | 2015 | 18 | 0.880 |
Why?
|
Hypercholesterolemia | 13 | 2012 | 1141 | 0.860 |
Why?
|
Humans | 437 | 2024 | 761222 | 0.860 |
Why?
|
Myocardial Infarction | 42 | 2024 | 11476 | 0.850 |
Why?
|
Apolipoprotein A-II | 4 | 2019 | 41 | 0.820 |
Why?
|
Fatty Acids | 14 | 2020 | 1807 | 0.820 |
Why?
|
Cholesterol, VLDL | 9 | 2010 | 70 | 0.810 |
Why?
|
Male | 276 | 2024 | 360703 | 0.780 |
Why?
|
Fatty Acids, Omega-3 | 14 | 2016 | 1390 | 0.770 |
Why?
|
Dietary Fiber | 12 | 2021 | 758 | 0.770 |
Why?
|
Female | 280 | 2024 | 392552 | 0.770 |
Why?
|
Lipoprotein(a) | 7 | 2014 | 482 | 0.760 |
Why?
|
Pancreatitis, Chronic | 2 | 2014 | 280 | 0.750 |
Why?
|
Nutrition Policy | 5 | 2017 | 466 | 0.740 |
Why?
|
Lutein | 1 | 2021 | 123 | 0.740 |
Why?
|
Patient Compliance | 17 | 2019 | 2688 | 0.720 |
Why?
|
Adult | 204 | 2024 | 221120 | 0.710 |
Why?
|
Waist Circumference | 13 | 2024 | 933 | 0.680 |
Why?
|
Carotenoids | 5 | 2021 | 621 | 0.650 |
Why?
|
Cross-Over Studies | 20 | 2023 | 2082 | 0.640 |
Why?
|
Benzimidazoles | 2 | 2014 | 858 | 0.630 |
Why?
|
Body Composition | 13 | 2022 | 2427 | 0.610 |
Why?
|
Dementia | 2 | 2023 | 2684 | 0.600 |
Why?
|
Genotype | 38 | 2023 | 12985 | 0.600 |
Why?
|
Energy Intake | 20 | 2024 | 2133 | 0.600 |
Why?
|
Diet, Vegetarian | 11 | 2019 | 180 | 0.590 |
Why?
|
Aged | 139 | 2024 | 169292 | 0.580 |
Why?
|
Life Style | 16 | 2020 | 3907 | 0.580 |
Why?
|
Lipids | 28 | 2017 | 3331 | 0.570 |
Why?
|
Risk Factors | 94 | 2024 | 74241 | 0.560 |
Why?
|
Fatty Acids, Monounsaturated | 5 | 2008 | 190 | 0.560 |
Why?
|
Appetite | 5 | 2020 | 247 | 0.560 |
Why?
|
Isoflavones | 3 | 2006 | 136 | 0.550 |
Why?
|
Monocytes | 5 | 2019 | 2570 | 0.540 |
Why?
|
Soybean Proteins | 2 | 2006 | 55 | 0.520 |
Why?
|
Fatty Acids, Omega-6 | 2 | 2009 | 225 | 0.520 |
Why?
|
Polymorphism, Single Nucleotide | 28 | 2020 | 15920 | 0.510 |
Why?
|
Feeding Behavior | 11 | 2020 | 3183 | 0.510 |
Why?
|
Benzodiazepines | 1 | 2021 | 1134 | 0.500 |
Why?
|
Eggs | 8 | 2020 | 182 | 0.490 |
Why?
|
Liver | 11 | 2020 | 7512 | 0.480 |
Why?
|
Motivation | 2 | 2021 | 2002 | 0.480 |
Why?
|
Body Mass Index | 35 | 2024 | 12952 | 0.480 |
Why?
|
Blood Glucose | 16 | 2023 | 6392 | 0.470 |
Why?
|
Health Behavior | 4 | 2021 | 2641 | 0.470 |
Why?
|
Heart Diseases | 5 | 2014 | 2795 | 0.470 |
Why?
|
Coronary Artery Disease | 16 | 2024 | 6506 | 0.470 |
Why?
|
Lipoprotein Lipase | 4 | 2015 | 133 | 0.460 |
Why?
|
Nutritional Physiological Phenomena | 6 | 2006 | 361 | 0.450 |
Why?
|
Polymorphism, Genetic | 10 | 2010 | 4243 | 0.450 |
Why?
|
Postmenopause | 7 | 2004 | 2514 | 0.450 |
Why?
|
Kinetics | 13 | 2023 | 6312 | 0.450 |
Why?
|
Sodium Chloride, Dietary | 7 | 2022 | 292 | 0.440 |
Why?
|
Health Promotion | 4 | 2021 | 2205 | 0.430 |
Why?
|
Double-Blind Method | 42 | 2024 | 12341 | 0.430 |
Why?
|
Energy Metabolism | 7 | 2022 | 2877 | 0.420 |
Why?
|
Prospective Studies | 53 | 2024 | 54437 | 0.410 |
Why?
|
Heptanoic Acids | 3 | 2005 | 344 | 0.410 |
Why?
|
Estrogen Replacement Therapy | 10 | 2011 | 1208 | 0.410 |
Why?
|
Proteome | 2 | 2019 | 1856 | 0.400 |
Why?
|
Particle Size | 9 | 2021 | 1649 | 0.400 |
Why?
|
Bile Acids and Salts | 3 | 2024 | 394 | 0.400 |
Why?
|
Fish Oils | 10 | 2002 | 483 | 0.400 |
Why?
|
Basal Metabolism | 2 | 2013 | 161 | 0.400 |
Why?
|
Sodium | 7 | 2023 | 1589 | 0.380 |
Why?
|
Proteomics | 3 | 2023 | 3840 | 0.380 |
Why?
|
Phospholipids | 7 | 2015 | 784 | 0.380 |
Why?
|
Estradiol | 5 | 1999 | 1937 | 0.360 |
Why?
|
Receptor, Melatonin, MT2 | 4 | 2023 | 82 | 0.360 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 2 | 2021 | 33 | 0.350 |
Why?
|
Cardiovascular System | 4 | 2010 | 836 | 0.350 |
Why?
|
Protein Kinase C-alpha | 2 | 2006 | 113 | 0.330 |
Why?
|
Vegetables | 11 | 2021 | 1192 | 0.330 |
Why?
|
Cognition | 5 | 2023 | 6988 | 0.330 |
Why?
|
Sodium, Dietary | 8 | 2010 | 425 | 0.330 |
Why?
|
Randomized Controlled Trials as Topic | 31 | 2023 | 10218 | 0.320 |
Why?
|
Methylamines | 3 | 2019 | 136 | 0.320 |
Why?
|
Case-Control Studies | 25 | 2019 | 22174 | 0.320 |
Why?
|
Oligonucleotides | 1 | 2012 | 563 | 0.320 |
Why?
|
Food Analysis | 5 | 2017 | 103 | 0.310 |
Why?
|
Circadian Rhythm | 7 | 2018 | 2569 | 0.310 |
Why?
|
Albuminuria | 2 | 2011 | 656 | 0.310 |
Why?
|
Diabetic Nephropathies | 2 | 2013 | 973 | 0.310 |
Why?
|
Body Weight | 19 | 2023 | 4618 | 0.310 |
Why?
|
C-Reactive Protein | 8 | 2023 | 3821 | 0.310 |
Why?
|
Pyrroles | 3 | 2005 | 1124 | 0.300 |
Why?
|
Internationality | 1 | 2013 | 999 | 0.300 |
Why?
|
Recurrence | 24 | 2024 | 8457 | 0.300 |
Why?
|
Insulin | 20 | 2022 | 6588 | 0.300 |
Why?
|
Health | 4 | 2010 | 398 | 0.290 |
Why?
|
Stroke | 10 | 2024 | 9721 | 0.290 |
Why?
|
Abdominal Fat | 4 | 2020 | 221 | 0.290 |
Why?
|
Risk Assessment | 29 | 2024 | 24022 | 0.280 |
Why?
|
Treatment Outcome | 47 | 2020 | 64681 | 0.280 |
Why?
|
Independent Living | 2 | 2021 | 579 | 0.280 |
Why?
|
Niacin | 6 | 2012 | 117 | 0.280 |
Why?
|
Pertussis Toxin | 1 | 2006 | 176 | 0.270 |
Why?
|
DNA Methylation | 5 | 2023 | 4384 | 0.270 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 805 | 0.270 |
Why?
|
Asparagine | 1 | 2006 | 120 | 0.270 |
Why?
|
United States | 45 | 2023 | 72341 | 0.270 |
Why?
|
Adiponectin | 3 | 2017 | 1107 | 0.270 |
Why?
|
Biological Transport | 5 | 2018 | 2081 | 0.270 |
Why?
|
Endothelium, Vascular | 4 | 2008 | 4420 | 0.260 |
Why?
|
Follow-Up Studies | 37 | 2023 | 39127 | 0.260 |
Why?
|
Amino Acids, Branched-Chain | 3 | 2020 | 269 | 0.260 |
Why?
|
Magnesium | 6 | 1998 | 804 | 0.250 |
Why?
|
Fats, Unsaturated | 4 | 2022 | 21 | 0.250 |
Why?
|
Fatty Acids, Unsaturated | 8 | 2013 | 540 | 0.250 |
Why?
|
Bone Density | 4 | 2021 | 3546 | 0.250 |
Why?
|
Chromatography, Affinity | 4 | 2012 | 525 | 0.250 |
Why?
|
Cholesterol, Dietary | 8 | 2005 | 224 | 0.250 |
Why?
|
Models, Psychological | 1 | 2009 | 830 | 0.250 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2012 | 691 | 0.240 |
Why?
|
Gonadal Steroid Hormones | 3 | 1995 | 702 | 0.240 |
Why?
|
Risk | 20 | 2016 | 9616 | 0.240 |
Why?
|
Genetic Variation | 12 | 2019 | 6567 | 0.240 |
Why?
|
Phytoestrogens | 1 | 2005 | 59 | 0.240 |
Why?
|
Estrogens, Esterified (USP) | 1 | 2004 | 1 | 0.240 |
Why?
|
Methyltestosterone | 1 | 2004 | 19 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 16 | 2019 | 17897 | 0.240 |
Why?
|
Chylomicrons | 2 | 2023 | 26 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2010 | 10756 | 0.230 |
Why?
|
Diabetic Retinopathy | 1 | 2013 | 1276 | 0.230 |
Why?
|
Aspartic Acid | 1 | 2006 | 574 | 0.230 |
Why?
|
Contraceptives, Oral | 3 | 1999 | 554 | 0.230 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2023 | 1725 | 0.230 |
Why?
|
Potassium | 4 | 1998 | 1309 | 0.220 |
Why?
|
Kidney Failure, Chronic | 4 | 2011 | 2478 | 0.220 |
Why?
|
Incidence | 19 | 2024 | 21366 | 0.220 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2023 | 82 | 0.220 |
Why?
|
Alleles | 13 | 2016 | 6857 | 0.220 |
Why?
|
Amino Acids | 3 | 2018 | 1703 | 0.210 |
Why?
|
Estrogens | 6 | 1999 | 1522 | 0.210 |
Why?
|
Diabetes Mellitus | 9 | 2016 | 5842 | 0.210 |
Why?
|
Neuropeptide Y | 2 | 2015 | 192 | 0.210 |
Why?
|
NF-kappa B | 4 | 2012 | 2475 | 0.210 |
Why?
|
Risk Reduction Behavior | 6 | 2014 | 1111 | 0.210 |
Why?
|
Linear Models | 13 | 2019 | 5869 | 0.210 |
Why?
|
Hypolipoproteinemias | 1 | 2002 | 2 | 0.210 |
Why?
|
Receptors, Fc | 1 | 2006 | 537 | 0.210 |
Why?
|
Body Fat Distribution | 3 | 2016 | 245 | 0.210 |
Why?
|
Phytotherapy | 1 | 2005 | 296 | 0.210 |
Why?
|
Carnitine | 3 | 2019 | 252 | 0.210 |
Why?
|
Marital Status | 2 | 2014 | 425 | 0.210 |
Why?
|
Uric Acid | 2 | 2021 | 807 | 0.210 |
Why?
|
Fasting | 8 | 2018 | 1603 | 0.200 |
Why?
|
Editorial Policies | 1 | 2007 | 458 | 0.200 |
Why?
|
Conflict of Interest | 1 | 2007 | 554 | 0.200 |
Why?
|
Fruit | 10 | 2010 | 1158 | 0.200 |
Why?
|
GTP-Binding Proteins | 1 | 2006 | 946 | 0.200 |
Why?
|
Cause of Death | 6 | 2015 | 3688 | 0.200 |
Why?
|
alpha-Linolenic Acid | 2 | 2013 | 144 | 0.200 |
Why?
|
Butadienes | 1 | 2002 | 107 | 0.200 |
Why?
|
Choline | 3 | 2019 | 515 | 0.200 |
Why?
|
Ultracentrifugation | 3 | 2012 | 182 | 0.200 |
Why?
|
Apolipoprotein B-48 | 3 | 2006 | 20 | 0.200 |
Why?
|
Cohort Studies | 24 | 2021 | 41496 | 0.200 |
Why?
|
Adipose Tissue | 9 | 2017 | 3313 | 0.190 |
Why?
|
Lipase | 3 | 2015 | 320 | 0.190 |
Why?
|
Insulin Receptor Substrate Proteins | 3 | 2013 | 557 | 0.190 |
Why?
|
Azetidines | 1 | 2002 | 142 | 0.190 |
Why?
|
Eicosapentaenoic Acid | 7 | 2016 | 561 | 0.190 |
Why?
|
Diabetes Complications | 3 | 2003 | 1316 | 0.190 |
Why?
|
Peptide Fragments | 5 | 2023 | 5103 | 0.190 |
Why?
|
Kidney Diseases | 7 | 2011 | 2092 | 0.190 |
Why?
|
Angina, Unstable | 2 | 2005 | 890 | 0.180 |
Why?
|
Endothelial Cells | 3 | 2012 | 3552 | 0.180 |
Why?
|
Fatty Acids, Volatile | 1 | 2021 | 103 | 0.180 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2020 | 61 | 0.180 |
Why?
|
Salivary alpha-Amylases | 1 | 2020 | 15 | 0.180 |
Why?
|
Proportional Hazards Models | 16 | 2019 | 12474 | 0.180 |
Why?
|
Drug Therapy, Combination | 8 | 2010 | 6304 | 0.180 |
Why?
|
Nutrition Therapy | 1 | 2021 | 102 | 0.180 |
Why?
|
Glomerular Filtration Rate | 6 | 2019 | 2182 | 0.180 |
Why?
|
Kidney | 3 | 2011 | 7033 | 0.170 |
Why?
|
Time Factors | 25 | 2018 | 39957 | 0.170 |
Why?
|
Simvastatin | 1 | 2002 | 346 | 0.170 |
Why?
|
Troponin I | 2 | 2023 | 652 | 0.170 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2021 | 90 | 0.170 |
Why?
|
Cardiology | 3 | 2019 | 1693 | 0.170 |
Why?
|
Esters | 1 | 2021 | 210 | 0.170 |
Why?
|
Carbohydrates | 1 | 2022 | 389 | 0.170 |
Why?
|
Carcinogens | 1 | 2002 | 452 | 0.170 |
Why?
|
Obesity, Abdominal | 3 | 2022 | 373 | 0.170 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 296 | 0.170 |
Why?
|
Nutritional Status | 4 | 2021 | 1597 | 0.170 |
Why?
|
Protein Binding | 4 | 2018 | 9297 | 0.170 |
Why?
|
Morbidity | 1 | 2005 | 1751 | 0.160 |
Why?
|
Glycoproteins | 4 | 2005 | 2203 | 0.160 |
Why?
|
Clusterin | 1 | 2019 | 71 | 0.160 |
Why?
|
Meat | 4 | 2023 | 584 | 0.160 |
Why?
|
Models, Biological | 6 | 2021 | 9458 | 0.160 |
Why?
|
Carrier Proteins | 6 | 2022 | 4935 | 0.160 |
Why?
|
Denmark | 2 | 2018 | 770 | 0.160 |
Why?
|
Regression Analysis | 12 | 2017 | 6345 | 0.160 |
Why?
|
Docosahexaenoic Acids | 7 | 2016 | 906 | 0.150 |
Why?
|
Computers | 2 | 2012 | 591 | 0.150 |
Why?
|
Practice Guidelines as Topic | 6 | 2021 | 7400 | 0.150 |
Why?
|
MicroRNAs | 3 | 2024 | 3758 | 0.150 |
Why?
|
Multicenter Studies as Topic | 5 | 2020 | 1702 | 0.150 |
Why?
|
Dairy Products | 6 | 2010 | 490 | 0.150 |
Why?
|
Amides | 1 | 2021 | 449 | 0.150 |
Why?
|
Sodium Chloride | 2 | 2017 | 584 | 0.150 |
Why?
|
Odds Ratio | 8 | 2014 | 9652 | 0.150 |
Why?
|
Eating | 2 | 2023 | 1535 | 0.150 |
Why?
|
Glucose Tolerance Test | 1 | 2021 | 1178 | 0.150 |
Why?
|
Mass Spectrometry | 3 | 2021 | 2189 | 0.150 |
Why?
|
Potassium Chloride | 2 | 1995 | 229 | 0.150 |
Why?
|
Cooking | 3 | 2017 | 309 | 0.150 |
Why?
|
Actigraphy | 1 | 2022 | 522 | 0.150 |
Why?
|
Lactase | 1 | 2018 | 71 | 0.150 |
Why?
|
Antioxidants | 3 | 2018 | 1667 | 0.150 |
Why?
|
Pancreatic alpha-Amylases | 1 | 2017 | 7 | 0.150 |
Why?
|
Glycerolphosphate Dehydrogenase | 1 | 2017 | 37 | 0.140 |
Why?
|
Lactic Acid | 2 | 2020 | 1139 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 2 | 2010 | 344 | 0.140 |
Why?
|
DNA | 3 | 2012 | 7189 | 0.140 |
Why?
|
Secondary Prevention | 6 | 2024 | 1472 | 0.140 |
Why?
|
Arteriosclerosis | 5 | 1998 | 1056 | 0.140 |
Why?
|
Cell Adhesion | 4 | 2012 | 3091 | 0.140 |
Why?
|
Nutritive Value | 2 | 2019 | 347 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2018 | 174 | 0.140 |
Why?
|
Genetic Association Studies | 5 | 2019 | 2731 | 0.140 |
Why?
|
Amino Acids, Aromatic | 2 | 2016 | 36 | 0.140 |
Why?
|
Hemostasis | 2 | 2018 | 470 | 0.140 |
Why?
|
Rest | 2 | 2012 | 920 | 0.140 |
Why?
|
Glucose | 5 | 2023 | 4342 | 0.140 |
Why?
|
Protein Stability | 1 | 2018 | 579 | 0.140 |
Why?
|
Food, Fortified | 2 | 1995 | 189 | 0.140 |
Why?
|
Deoxyglucose | 1 | 2017 | 333 | 0.140 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2017 | 129 | 0.130 |
Why?
|
Clinical Trials as Topic | 14 | 2005 | 8002 | 0.130 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2015 | 6 | 0.130 |
Why?
|
Aged, 80 and over | 20 | 2023 | 58952 | 0.130 |
Why?
|
Health Education | 2 | 2021 | 1049 | 0.130 |
Why?
|
Periodicals as Topic | 1 | 2007 | 1463 | 0.130 |
Why?
|
Taurine | 1 | 2016 | 92 | 0.130 |
Why?
|
Antigens, CD | 1 | 2006 | 4009 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 3803 | 0.130 |
Why?
|
Thyroid Hormones | 2 | 2017 | 402 | 0.130 |
Why?
|
Satiation | 2 | 2009 | 82 | 0.130 |
Why?
|
Vitamin D | 3 | 2021 | 3301 | 0.130 |
Why?
|
Reference Values | 7 | 2008 | 4921 | 0.130 |
Why?
|
Indoles | 1 | 2003 | 1830 | 0.130 |
Why?
|
Prognosis | 13 | 2022 | 29688 | 0.130 |
Why?
|
Margarine | 1 | 1995 | 17 | 0.130 |
Why?
|
Predictive Value of Tests | 8 | 2018 | 15308 | 0.120 |
Why?
|
Postprandial Period | 3 | 2007 | 314 | 0.120 |
Why?
|
Genome-Wide Association Study | 10 | 2023 | 12676 | 0.120 |
Why?
|
Infusions, Intravenous | 3 | 2024 | 2217 | 0.120 |
Why?
|
Quinolines | 2 | 2012 | 764 | 0.120 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3031 | 0.120 |
Why?
|
Administration, Oral | 7 | 2004 | 4015 | 0.120 |
Why?
|
Czechoslovakia | 1 | 2014 | 6 | 0.120 |
Why?
|
Hyperglycemia | 2 | 2017 | 1375 | 0.120 |
Why?
|
Proteins | 3 | 2015 | 5993 | 0.120 |
Why?
|
Subtilisins | 1 | 2014 | 79 | 0.120 |
Why?
|
Vasomotor System | 1 | 1995 | 208 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 790 | 0.120 |
Why?
|
Multivariate Analysis | 10 | 2019 | 12052 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 353 | 0.120 |
Why?
|
Chemistry | 1 | 2014 | 325 | 0.120 |
Why?
|
Plant Oils | 5 | 2010 | 198 | 0.110 |
Why?
|
Vascular Diseases | 2 | 2015 | 1160 | 0.110 |
Why?
|
Serum Amyloid P-Component | 1 | 2014 | 46 | 0.110 |
Why?
|
Cryptochromes | 1 | 2013 | 48 | 0.110 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2013 | 31 | 0.110 |
Why?
|
Blood Vessels | 1 | 2019 | 1111 | 0.110 |
Why?
|
Deuterium | 2 | 2021 | 106 | 0.110 |
Why?
|
Logistic Models | 8 | 2010 | 13249 | 0.110 |
Why?
|
Alzheimer Disease | 3 | 2021 | 8606 | 0.110 |
Why?
|
Coffee | 2 | 2017 | 593 | 0.110 |
Why?
|
Models, Cardiovascular | 1 | 2019 | 983 | 0.110 |
Why?
|
Calcium | 2 | 1998 | 5719 | 0.110 |
Why?
|
Genetic Determinism | 1 | 2013 | 10 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 1996 | 488 | 0.110 |
Why?
|
Cholesterol Esters | 3 | 1995 | 72 | 0.110 |
Why?
|
Pharmacogenetics | 2 | 2021 | 675 | 0.110 |
Why?
|
Cell Line | 6 | 2009 | 15545 | 0.110 |
Why?
|
Menopause | 7 | 1993 | 1646 | 0.110 |
Why?
|
Placebos | 6 | 2011 | 1666 | 0.100 |
Why?
|
Fibric Acids | 1 | 2012 | 27 | 0.100 |
Why?
|
Exercise | 7 | 2022 | 5874 | 0.100 |
Why?
|
Coronary Angiography | 7 | 1995 | 4507 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 989 | 0.100 |
Why?
|
Psychiatry | 1 | 2005 | 1699 | 0.100 |
Why?
|
Leucine | 2 | 2010 | 546 | 0.100 |
Why?
|
Absorptiometry, Photon | 5 | 2019 | 1738 | 0.100 |
Why?
|
Behavior | 2 | 2019 | 540 | 0.100 |
Why?
|
Placebo Effect | 1 | 2016 | 518 | 0.100 |
Why?
|
Anthropometry | 1 | 2017 | 1338 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 1085 | 0.100 |
Why?
|
Patient Identification Systems | 1 | 2012 | 75 | 0.100 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2012 | 152 | 0.100 |
Why?
|
Receptors, Gastrointestinal Hormone | 1 | 2012 | 39 | 0.100 |
Why?
|
Primary Prevention | 3 | 2015 | 1185 | 0.100 |
Why?
|
Calcinosis | 1 | 2021 | 1477 | 0.100 |
Why?
|
Probability | 4 | 2008 | 2478 | 0.100 |
Why?
|
Behavior Therapy | 2 | 2014 | 875 | 0.100 |
Why?
|
Research Design | 6 | 2005 | 6180 | 0.100 |
Why?
|
Cerebrovascular Disorders | 4 | 2012 | 1474 | 0.100 |
Why?
|
Animals | 27 | 2019 | 168089 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 877 | 0.090 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2011 | 60 | 0.090 |
Why?
|
Los Angeles | 1 | 2011 | 244 | 0.090 |
Why?
|
Diet Records | 5 | 2017 | 427 | 0.090 |
Why?
|
Blood Pressure Determination | 4 | 2019 | 633 | 0.090 |
Why?
|
Aortic Valve | 1 | 2021 | 1959 | 0.090 |
Why?
|
Renin | 1 | 2013 | 639 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 863 | 0.090 |
Why?
|
Louisiana | 3 | 2016 | 103 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 1998 | 1985 | 0.090 |
Why?
|
Heart Failure | 5 | 2022 | 11701 | 0.090 |
Why?
|
Diet Fads | 2 | 2008 | 13 | 0.090 |
Why?
|
Atrial Fibrillation | 3 | 2014 | 5114 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2254 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7804 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1885 | 0.090 |
Why?
|
Triticum | 1 | 1990 | 90 | 0.080 |
Why?
|
Exercise Therapy | 2 | 2014 | 922 | 0.080 |
Why?
|
Diet Surveys | 6 | 2015 | 1161 | 0.080 |
Why?
|
Societies, Medical | 2 | 2019 | 3923 | 0.080 |
Why?
|
Microvessels | 1 | 2013 | 580 | 0.080 |
Why?
|
Acute Coronary Syndrome | 2 | 2013 | 2194 | 0.080 |
Why?
|
Prazosin | 1 | 1989 | 95 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 2017 | 1780 | 0.080 |
Why?
|
Analysis of Variance | 6 | 2008 | 6223 | 0.080 |
Why?
|
Scavenger Receptors, Class B | 1 | 2009 | 85 | 0.080 |
Why?
|
Insulin-Secreting Cells | 1 | 2016 | 898 | 0.080 |
Why?
|
Trans Fatty Acids | 1 | 2010 | 155 | 0.080 |
Why?
|
Gene Frequency | 3 | 2014 | 3603 | 0.080 |
Why?
|
Feedback | 1 | 2012 | 790 | 0.080 |
Why?
|
Seafood | 1 | 2012 | 393 | 0.080 |
Why?
|
Food Preferences | 1 | 2012 | 398 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 4 | 2014 | 244 | 0.080 |
Why?
|
Phenylalanine | 1 | 2010 | 364 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4077 | 0.080 |
Why?
|
Diet, Atherogenic | 2 | 2005 | 92 | 0.080 |
Why?
|
Menu Planning | 1 | 2008 | 28 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2018 | 0.080 |
Why?
|
Inflammation | 4 | 2023 | 10759 | 0.080 |
Why?
|
Comorbidity | 6 | 2005 | 10516 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 602 | 0.070 |
Why?
|
History, 21st Century | 1 | 2014 | 1567 | 0.070 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 26072 | 0.070 |
Why?
|
Heterozygote | 5 | 2015 | 2778 | 0.070 |
Why?
|
Sex Factors | 10 | 2017 | 10553 | 0.070 |
Why?
|
Europe | 4 | 2020 | 3423 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3571 | 0.070 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2009 | 411 | 0.070 |
Why?
|
PPAR alpha | 1 | 2008 | 175 | 0.070 |
Why?
|
Dietary Sucrose | 1 | 2009 | 243 | 0.070 |
Why?
|
Linoleic Acids | 1 | 1987 | 39 | 0.070 |
Why?
|
Aorta | 3 | 2012 | 2040 | 0.070 |
Why?
|
Osmolar Concentration | 2 | 1999 | 659 | 0.070 |
Why?
|
Disease Progression | 7 | 2020 | 13511 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2016 | 15841 | 0.070 |
Why?
|
Arginine | 2 | 2008 | 920 | 0.070 |
Why?
|
Propranolol | 1 | 1989 | 490 | 0.070 |
Why?
|
Norbornanes | 1 | 2006 | 10 | 0.070 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2006 | 20 | 0.070 |
Why?
|
Ghrelin | 1 | 2009 | 251 | 0.070 |
Why?
|
Thiocarbamates | 1 | 2006 | 30 | 0.070 |
Why?
|
Macrophages | 2 | 1996 | 5755 | 0.070 |
Why?
|
Oleic Acids | 1 | 1987 | 72 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2012 | 901 | 0.070 |
Why?
|
Thiones | 1 | 2006 | 46 | 0.070 |
Why?
|
Blood Viscosity | 1 | 1987 | 124 | 0.070 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 998 | 0.070 |
Why?
|
Scotland | 1 | 2006 | 143 | 0.070 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2008 | 323 | 0.070 |
Why?
|
Diet, Protein-Restricted | 2 | 2018 | 72 | 0.070 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1987 | 174 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2009 | 859 | 0.070 |
Why?
|
Forearm | 1 | 1989 | 427 | 0.070 |
Why?
|
Sympatholytics | 1 | 1986 | 82 | 0.070 |
Why?
|
Electrolytes | 1 | 1987 | 274 | 0.070 |
Why?
|
Biology | 2 | 2023 | 290 | 0.070 |
Why?
|
History, 20th Century | 1 | 2014 | 2765 | 0.070 |
Why?
|
Schizophrenia | 1 | 2005 | 6930 | 0.070 |
Why?
|
Longitudinal Studies | 6 | 2014 | 14610 | 0.060 |
Why?
|
Leptin | 2 | 2017 | 1595 | 0.060 |
Why?
|
Proteinuria | 2 | 2006 | 605 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 210 | 0.060 |
Why?
|
Aryldialkylphosphatase | 1 | 2005 | 64 | 0.060 |
Why?
|
Eicosanoic Acids | 2 | 2015 | 15 | 0.060 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2006 | 213 | 0.060 |
Why?
|
Young Adult | 3 | 2018 | 59222 | 0.060 |
Why?
|
Gene Expression Regulation | 5 | 2017 | 11855 | 0.060 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 563 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1838 | 0.060 |
Why?
|
Dietary Supplements | 3 | 2021 | 3410 | 0.060 |
Why?
|
Calcium Carbonate | 2 | 1995 | 62 | 0.060 |
Why?
|
Administration, Cutaneous | 3 | 1994 | 713 | 0.060 |
Why?
|
Protein Kinase C | 2 | 2008 | 1202 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 392 | 0.060 |
Why?
|
Stearic Acids | 2 | 2015 | 56 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2021 | 18927 | 0.060 |
Why?
|
beta Carotene | 4 | 1999 | 523 | 0.060 |
Why?
|
Salpingostomy | 1 | 2004 | 8 | 0.060 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2006 | 235 | 0.060 |
Why?
|
Fishes | 2 | 2002 | 600 | 0.060 |
Why?
|
Chicago | 2 | 2015 | 254 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3836 | 0.060 |
Why?
|
Erythrocytes | 2 | 2020 | 2413 | 0.060 |
Why?
|
Palmitic Acid | 2 | 2015 | 149 | 0.060 |
Why?
|
Survival Rate | 5 | 2010 | 12728 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2015 | 3976 | 0.060 |
Why?
|
Prevalence | 5 | 2013 | 15721 | 0.060 |
Why?
|
Antihypertensive Agents | 3 | 2014 | 2019 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3434 | 0.060 |
Why?
|
Food Handling | 1 | 2024 | 154 | 0.060 |
Why?
|
Diet Therapy | 1 | 2005 | 151 | 0.060 |
Why?
|
Plasma Membrane Calcium-Transporting ATPases | 1 | 2023 | 17 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5773 | 0.050 |
Why?
|
Adipocytes | 1 | 2010 | 1190 | 0.050 |
Why?
|
Lactones | 1 | 2006 | 316 | 0.050 |
Why?
|
Massachusetts | 2 | 2018 | 8837 | 0.050 |
Why?
|
Caseins | 1 | 1983 | 104 | 0.050 |
Why?
|
Australia | 2 | 2002 | 1246 | 0.050 |
Why?
|
Glycochenodeoxycholic Acid | 1 | 2022 | 4 | 0.050 |
Why?
|
Atmospheric Pressure | 1 | 2002 | 46 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2507 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1173 | 0.050 |
Why?
|
Progestins | 2 | 1995 | 301 | 0.050 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 2022 | 35 | 0.050 |
Why?
|
Sleep | 2 | 2022 | 4759 | 0.050 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 1128 | 0.050 |
Why?
|
Pregnancy | 2 | 2014 | 29893 | 0.050 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2002 | 168 | 0.050 |
Why?
|
Fast Foods | 1 | 2024 | 210 | 0.050 |
Why?
|
Renal Insufficiency | 2 | 2005 | 808 | 0.050 |
Why?
|
Coronary Vessels | 3 | 2004 | 3111 | 0.050 |
Why?
|
Phosphates | 1 | 2005 | 763 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2005 | 965 | 0.050 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 1994 | 276 | 0.050 |
Why?
|
Alcohol Drinking | 7 | 2012 | 4027 | 0.050 |
Why?
|
Ovariectomy | 1 | 2004 | 614 | 0.050 |
Why?
|
Patient Dropouts | 1 | 2004 | 411 | 0.050 |
Why?
|
Food Industry | 1 | 2022 | 67 | 0.050 |
Why?
|
Drug Evaluation | 2 | 2004 | 641 | 0.050 |
Why?
|
Muscular Diseases | 2 | 2002 | 552 | 0.050 |
Why?
|
New Zealand | 1 | 2002 | 358 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2567 | 0.050 |
Why?
|
Asia | 2 | 2020 | 622 | 0.050 |
Why?
|
Angiotensinogen | 1 | 2001 | 160 | 0.050 |
Why?
|
Gases | 1 | 2002 | 204 | 0.050 |
Why?
|
Counseling | 1 | 2009 | 1536 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1987 | 1241 | 0.050 |
Why?
|
Temperature | 2 | 2002 | 2219 | 0.050 |
Why?
|
Autoantigens | 1 | 2005 | 888 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 1995 | 1097 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3577 | 0.040 |
Why?
|
Alcohol Dehydrogenase | 1 | 2001 | 113 | 0.040 |
Why?
|
Survival Analysis | 5 | 2015 | 10088 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6067 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2010 | 3210 | 0.040 |
Why?
|
Body Constitution | 1 | 2000 | 273 | 0.040 |
Why?
|
Mice | 9 | 2019 | 81330 | 0.040 |
Why?
|
Angina Pectoris | 1 | 2004 | 959 | 0.040 |
Why?
|
Netherlands | 1 | 2005 | 2222 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2006 | 1385 | 0.040 |
Why?
|
Age Factors | 9 | 2013 | 18384 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9567 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2005 | 1251 | 0.040 |
Why?
|
Drug Synergism | 1 | 2004 | 1756 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2001 | 328 | 0.040 |
Why?
|
Smoking | 5 | 2012 | 9055 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 4 | 2004 | 1724 | 0.040 |
Why?
|
Random Allocation | 4 | 1989 | 2393 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2001 | 144 | 0.040 |
Why?
|
Costa Rica | 2 | 2010 | 180 | 0.040 |
Why?
|
Wounds, Stab | 1 | 1979 | 72 | 0.040 |
Why?
|
Resins, Synthetic | 1 | 1999 | 25 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2003 | 982 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2021 | 436 | 0.040 |
Why?
|
Acinetobacter Infections | 1 | 1979 | 72 | 0.040 |
Why?
|
Kidney Function Tests | 3 | 2005 | 680 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1791 | 0.040 |
Why?
|
Hysterectomy | 1 | 2004 | 857 | 0.040 |
Why?
|
Calcium, Dietary | 3 | 1998 | 529 | 0.040 |
Why?
|
Protein Precursors | 2 | 2020 | 1132 | 0.040 |
Why?
|
Weight Gain | 2 | 2022 | 2349 | 0.040 |
Why?
|
Canada | 2 | 2002 | 2125 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2643 | 0.040 |
Why?
|
Molecular Weight | 1 | 2021 | 2171 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2008 | 4851 | 0.040 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2001 | 578 | 0.040 |
Why?
|
Homeostasis | 3 | 2014 | 3322 | 0.040 |
Why?
|
Intra-Abdominal Fat | 2 | 2015 | 612 | 0.040 |
Why?
|
Boston | 4 | 2016 | 9327 | 0.040 |
Why?
|
Patient Selection | 4 | 2011 | 4246 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 1999 | 368 | 0.040 |
Why?
|
Chronic Disease | 3 | 2008 | 9319 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2015 | 2640 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1999 | 186 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 780 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2000 | 590 | 0.040 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 130 | 0.040 |
Why?
|
Bifidobacterium | 1 | 2018 | 96 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12101 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 470 | 0.040 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 173 | 0.040 |
Why?
|
Aspirin | 4 | 2004 | 3129 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1417 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1723 | 0.040 |
Why?
|
Aging | 2 | 2015 | 8702 | 0.030 |
Why?
|
Nuts | 1 | 1999 | 264 | 0.030 |
Why?
|
Intestines | 1 | 2006 | 1908 | 0.030 |
Why?
|
Life Expectancy | 1 | 2024 | 1242 | 0.030 |
Why?
|
Sensitivity and Specificity | 5 | 2003 | 14675 | 0.030 |
Why?
|
Communicable Diseases | 1 | 2005 | 873 | 0.030 |
Why?
|
Brain | 1 | 2023 | 27094 | 0.030 |
Why?
|
Autoantibodies | 1 | 2005 | 2119 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3417 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1993 | 8998 | 0.030 |
Why?
|
International Cooperation | 2 | 2014 | 1423 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8519 | 0.030 |
Why?
|
Health Personnel | 2 | 2006 | 3337 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2004 | 1496 | 0.030 |
Why?
|
Butter | 1 | 1995 | 22 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1999 | 2561 | 0.030 |
Why?
|
Lipoproteins, HDL2 | 1 | 1994 | 2 | 0.030 |
Why?
|
Lipoproteins, HDL3 | 1 | 1994 | 2 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1979 | 436 | 0.030 |
Why?
|
Down-Regulation | 2 | 2016 | 2916 | 0.030 |
Why?
|
Intracranial Arteriosclerosis | 1 | 1996 | 138 | 0.030 |
Why?
|
Cholestyramine Resin | 1 | 1994 | 25 | 0.030 |
Why?
|
Gemfibrozil | 1 | 1994 | 30 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3453 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2018 | 362 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2104 | 0.030 |
Why?
|
Systole | 3 | 2001 | 936 | 0.030 |
Why?
|
Cystatin C | 1 | 2016 | 270 | 0.030 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2015 | 91 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2019 | 803 | 0.030 |
Why?
|
Motor Activity | 2 | 2014 | 2712 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2017 | 727 | 0.030 |
Why?
|
Coronary Artery Bypass | 3 | 1999 | 2193 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3114 | 0.030 |
Why?
|
Receptors, LDL | 2 | 2005 | 489 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2007 | 3200 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6486 | 0.030 |
Why?
|
Self-Help Groups | 1 | 2014 | 192 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2004 | 2746 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2599 | 0.030 |
Why?
|
Smoking Cessation | 1 | 2005 | 2056 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2017 | 20118 | 0.030 |
Why?
|
Psychological Tests | 1 | 2015 | 639 | 0.030 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3899 | 0.030 |
Why?
|
Intermittent Claudication | 1 | 1995 | 304 | 0.030 |
Why?
|
Executive Function | 1 | 2021 | 1388 | 0.030 |
Why?
|
Tanzania | 1 | 2017 | 1390 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1168 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 1994 | 726 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18222 | 0.030 |
Why?
|
Femur | 1 | 2018 | 1308 | 0.020 |
Why?
|
Fatty Acid Desaturases | 1 | 2012 | 101 | 0.020 |
Why?
|
Phenotype | 1 | 2010 | 16575 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2001 | 9187 | 0.020 |
Why?
|
Stroke Volume | 2 | 2022 | 5521 | 0.020 |
Why?
|
Meta-Analysis as Topic | 2 | 2011 | 1381 | 0.020 |
Why?
|
Mortality | 2 | 2015 | 2896 | 0.020 |
Why?
|
Tuna | 1 | 1991 | 18 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2013 | 328 | 0.020 |
Why?
|
Food Labeling | 1 | 1993 | 179 | 0.020 |
Why?
|
Belgium | 1 | 2011 | 119 | 0.020 |
Why?
|
Mental Recall | 1 | 2017 | 1221 | 0.020 |
Why?
|
Prostatic Neoplasms | 3 | 1999 | 11101 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2011 | 224 | 0.020 |
Why?
|
Myocarditis | 1 | 1998 | 792 | 0.020 |
Why?
|
Antibodies | 1 | 1999 | 2415 | 0.020 |
Why?
|
Hydrogenation | 1 | 2010 | 20 | 0.020 |
Why?
|
Adolescent | 7 | 2012 | 88300 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2706 | 0.020 |
Why?
|
Statistics as Topic | 2 | 1998 | 2359 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4037 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2004 | 3064 | 0.020 |
Why?
|
Needs Assessment | 1 | 2016 | 1141 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1741 | 0.020 |
Why?
|
Isomerism | 1 | 2010 | 197 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1995 | 2928 | 0.020 |
Why?
|
Breast Diseases | 1 | 1993 | 443 | 0.020 |
Why?
|
Individuality | 1 | 1991 | 303 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2016 | 680 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2012 | 516 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 1989 | 15 | 0.020 |
Why?
|
Nicotinic Acids | 1 | 1988 | 31 | 0.020 |
Why?
|
Blood Preservation | 1 | 1989 | 169 | 0.020 |
Why?
|
Creatine | 1 | 2011 | 427 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 4340 | 0.020 |
Why?
|
Potassium, Dietary | 2 | 2003 | 102 | 0.020 |
Why?
|
Diastole | 2 | 2001 | 782 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3691 | 0.020 |
Why?
|
Homozygote | 2 | 2005 | 1775 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7046 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 393 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1743 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1212 | 0.020 |
Why?
|
Protein Isoforms | 2 | 2004 | 1695 | 0.020 |
Why?
|
Transportation | 1 | 1989 | 217 | 0.020 |
Why?
|
Creatinine | 2 | 2004 | 1897 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 1993 | 1162 | 0.020 |
Why?
|
Professional Practice | 1 | 1990 | 313 | 0.020 |
Why?
|
Pneumonia | 1 | 1979 | 2142 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3620 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2012 | 22128 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5406 | 0.020 |
Why?
|
Oleic Acid | 1 | 1987 | 92 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3584 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 1987 | 135 | 0.020 |
Why?
|
Androgens | 1 | 1994 | 1283 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 1996 | 2004 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1992 | 1156 | 0.020 |
Why?
|
Iron | 1 | 2014 | 1791 | 0.020 |
Why?
|
Medication Adherence | 1 | 2018 | 2175 | 0.020 |
Why?
|
Blood Platelets | 2 | 2001 | 2477 | 0.020 |
Why?
|
Linoleic Acid | 1 | 1987 | 158 | 0.020 |
Why?
|
Rats | 2 | 2016 | 23705 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2020 | 80675 | 0.020 |
Why?
|
Isoprostanes | 1 | 2005 | 21 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 1989 | 589 | 0.020 |
Why?
|
Taq Polymerase | 1 | 2005 | 20 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 1989 | 1498 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 705 | 0.020 |
Why?
|
Medical Records | 1 | 2011 | 1409 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 1528 | 0.020 |
Why?
|
Specimen Handling | 1 | 1989 | 702 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1995 | 3702 | 0.010 |
Why?
|
Computational Biology | 1 | 2017 | 3499 | 0.010 |
Why?
|
Apoprotein(a) | 1 | 2004 | 17 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3418 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2317 | 0.010 |
Why?
|
Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2004 | 18 | 0.010 |
Why?
|
Testosterone | 1 | 1995 | 2472 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2623 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2012 | 2697 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1986 | 392 | 0.010 |
Why?
|
Vasodilation | 1 | 2008 | 966 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13402 | 0.010 |
Why?
|
Women's Health | 1 | 1993 | 2070 | 0.010 |
Why?
|
Mental Disorders | 1 | 2004 | 6823 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1280 | 0.010 |
Why?
|
Algorithms | 2 | 1996 | 14025 | 0.010 |
Why?
|
Pilot Projects | 2 | 1996 | 8642 | 0.010 |
Why?
|
Natriuresis | 1 | 2003 | 105 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1987 | 752 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 2005 | 439 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 585 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 518 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2010 | 1723 | 0.010 |
Why?
|
Glutamine | 1 | 2005 | 574 | 0.010 |
Why?
|
Hypotension | 1 | 1988 | 879 | 0.010 |
Why?
|
Physicians | 2 | 2004 | 4584 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12747 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3264 | 0.010 |
Why?
|
Minerals | 1 | 2003 | 281 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 1480 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2003 | 684 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9417 | 0.010 |
Why?
|
Mass Screening | 1 | 1996 | 5426 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3727 | 0.010 |
Why?
|
Myocardial Revascularization | 1 | 2004 | 794 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2277 | 0.010 |
Why?
|
Time | 1 | 2002 | 545 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3320 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3096 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2871 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2455 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2008 | 2137 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1577 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3271 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2369 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2864 | 0.010 |
Why?
|
Serum Amyloid A Protein | 1 | 1998 | 126 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2897 | 0.010 |
Why?
|
Buttocks | 1 | 1998 | 112 | 0.010 |
Why?
|
Cats | 1 | 1999 | 974 | 0.010 |
Why?
|
Demography | 1 | 2002 | 1641 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2005 | 2138 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1998 | 1308 | 0.010 |
Why?
|
Fibroblasts | 1 | 1987 | 4138 | 0.010 |
Why?
|
Isoenzymes | 1 | 2001 | 1682 | 0.010 |
Why?
|
Normal Distribution | 1 | 1996 | 272 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 1999 | 677 | 0.010 |
Why?
|
Cattle | 1 | 1981 | 3818 | 0.010 |
Why?
|
Fish Products | 1 | 1975 | 30 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 1975 | 163 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7226 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2691 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5478 | 0.010 |
Why?
|
Vitamins | 1 | 2003 | 1634 | 0.010 |
Why?
|
Glucose Intolerance | 1 | 1998 | 575 | 0.010 |
Why?
|
Nurses | 2 | 1998 | 2477 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2005 | 2726 | 0.010 |
Why?
|
Social Conditions | 1 | 1974 | 120 | 0.010 |
Why?
|
Cost Control | 1 | 1996 | 627 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1994 | 150 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1728 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4014 | 0.010 |
Why?
|
Gene Deletion | 1 | 2001 | 2658 | 0.010 |
Why?
|
Liver Diseases | 1 | 2002 | 1301 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2002 | 1201 | 0.010 |
Why?
|
Safety | 1 | 1998 | 1151 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1999 | 874 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30004 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2005 | 4537 | 0.010 |
Why?
|
Fibrinopeptide A | 1 | 1992 | 43 | 0.010 |
Why?
|
Protein S | 1 | 1992 | 29 | 0.010 |
Why?
|
Antithrombin III | 1 | 1992 | 128 | 0.010 |
Why?
|
Protein C | 1 | 1992 | 133 | 0.010 |
Why?
|
Prothrombin | 1 | 1992 | 192 | 0.010 |
Why?
|
Neoplasms | 1 | 2001 | 22142 | 0.010 |
Why?
|
Factor Xa | 1 | 1992 | 166 | 0.010 |
Why?
|
Bleeding Time | 1 | 1991 | 83 | 0.010 |
Why?
|
Absorption | 1 | 1991 | 242 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2002 | 20982 | 0.010 |
Why?
|
Up-Regulation | 1 | 2000 | 4111 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 5081 | 0.010 |
Why?
|
Lymphoma | 1 | 1999 | 1898 | 0.010 |
Why?
|
Arachidonic Acids | 1 | 1990 | 294 | 0.010 |
Why?
|
Thrombin | 1 | 1992 | 593 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 1995 | 988 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1990 | 427 | 0.000 |
Why?
|
Databases, Factual | 1 | 2004 | 7965 | 0.000 |
Why?
|
Tablets | 1 | 1988 | 148 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5493 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10203 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1991 | 771 | 0.000 |
Why?
|
Stress, Mechanical | 1 | 1993 | 1674 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1999 | 2527 | 0.000 |
Why?
|
Radiography | 1 | 1998 | 6974 | 0.000 |
Why?
|
Antigens | 1 | 1992 | 1441 | 0.000 |
Why?
|
Solubility | 1 | 1988 | 1085 | 0.000 |
Why?
|
Coronary Circulation | 1 | 1993 | 1611 | 0.000 |
Why?
|
Hormones | 1 | 1989 | 868 | 0.000 |
Why?
|
Vitamin E | 1 | 1989 | 872 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1988 | 1535 | 0.000 |
Why?
|
Delayed-Action Preparations | 1 | 1988 | 961 | 0.000 |
Why?
|
Residence Characteristics | 1 | 1974 | 2092 | 0.000 |
Why?
|
Melanoma | 1 | 1999 | 5694 | 0.000 |
Why?
|
Quality of Life | 1 | 2001 | 13367 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4473 | 0.000 |
Why?
|
Computer Simulation | 1 | 1993 | 6224 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1999 | 13386 | 0.000 |
Why?
|
Child, Preschool | 1 | 1974 | 42225 | 0.000 |
Why?
|
Child | 1 | 1974 | 80154 | 0.000 |
Why?
|